Anti-SOX1 antibodies-positive paraneoplastic neurological syndromes caused by thyroid carcinoma: A case report. [PDF]
Deng Y +6 more
europepmc +1 more source
Objective: There is still no consensus about whether to perform PET/CT to detect carcinoma in paraneoplastic neurological syndromes (PNS) in patients with or without antibodies.
Sonmezoglu, K. +6 more
core +1 more source
Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series. [PDF]
Giammello F +12 more
europepmc +1 more source
Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report. [PDF]
Song J +5 more
europepmc +1 more source
Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes. [PDF]
Bastiaansen AEM +9 more
europepmc +1 more source
Additional Value of [18F]FDG PET/CT in Detection of Suspected Malignancy in Patients with Paraneoplastic Neurological Syndromes Having Negative Results of Conventional Radiological Imaging. [PDF]
Opalińska M +5 more
europepmc +1 more source
Clinical Spectrum, Therapeutic Outcomes and Prognostic predictors in Paraneoplastic Neurological Syndromes - Experiences from a Tertiary Care Center in India. [PDF]
Vijayaraghavan A +13 more
europepmc +1 more source
The use of eye-movement recording in patients with anti-Hu antibody-associated paraneoplastic neurological syndromes to objectively determine extent and course of disease. [PDF]
Janssen M +4 more
europepmc +1 more source
Mechanisms of paraneoplastic neurological syndromes. [PDF]
Kunchok A, Vogrig A, Graus F.
europepmc +1 more source
Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy. [PDF]
Zaborowski MP +8 more
europepmc +1 more source

